Cargando…
Imatinib-induced Ototoxicity in a Patient with Gastrointestinal Stromal Tumor (GIST)
Imatinib (Gleevec) is a biological agent that is approved for the treatment of chronic myeloid leukemia (CML) as well as gastrointestinal stromal tumor (GIST). The most frequently seen adverse effects in patients treated with imatinib include superficial edema, muscle cramps, musculoskeletal pain, r...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120973/ https://www.ncbi.nlm.nih.gov/pubmed/27909636 http://dx.doi.org/10.7759/cureus.848 |